Search
for
Sort by
Research 601–630 of 1000+
- Baricitinib for the Treatment of Alopecia Areata
- Safety of Janus Kinase inhibitors in Patients with Alopecia Areata: A Systematic Review
- Treatment of chronic alopecia areata with tildrakizumab: an open‐label pilot study
- Adverse events in patients treated with Jak‐inhibitors for alopecia areata: A systematic review
- Chinese SLE Treatment and Research Group Registry (CSTAR) XIII: prevalence and risk factors for chronic scarring alopecia in patients with systemic lupus erythematosus
- Adverse effects of baricitinib in comparison to methotrexate in the treatment of severe alopecia areata
- ADVERSE EFFECTS OF RITLECITINIB IN ADULTS AND ADOLESCENTS WITH ALOPECIA AREATA: A LITERATURE REVIEW
- Safety and efficacy of tofacitinib in 97 alopecia areata patients
- Systemic Tofacitinib Treatment in Pediatric Patients with Resistant Alopecia Areata
- 69 Risk-benefit appraisal of systemic JAK inhibitors for alopecia areata: a comprehensive meta-analysis assessing safety and adverse effects
- EPH39 Alopecia Areata: Targeted Review of Adverse Events Associated with Clinical Studies of Treatments
- Anagen effluvium in extracorporeal membrane oxygenation
- Zinc in hair and urine of paediatric patients
- PREVALÊNCIA DE DISTÚRBIOS RESPIRATÓRIOS EM PACIENTES COM FISSURA LABIOPALATINA: REVISÃO SISTEMÁTICA
- Dynamic characteristics of cerebrovascular reactivity or ventilatory response to change in carbon dioxide
- Lupus Pneumonitis Masquerading As Community Acquired Pneumonia And Pulmonary Tuberculosis: A Case Report
- ВЛИЯНИЕ ЗАНЯТИЙ СПЕЦИФИЧЕСКОЙ МЫШЕЧНОЙ ДЕЯТЕЛЬНОСТЬЮ НА ФУНКЦИОНАЛЬНОЕ СОСТОЯНИЕ СТУДЕНТОВ СПЕЦИАЛЬНОГО МЕДИЦИНСКОГО ОТДЕЛЕНИЯ
- ADVERSE EFFECTS OF OPIOID ANALGESIC DRUGS
- Dupilumab: A Review of Present Indications and Off-Label Uses
- DIAGNÓSTICO E MANIFESTAÇÕES PRECOCES NA ASMA PEDIÁTRICA: O QUE SABEMOS?
- Failure of Fresh Plasma in Leiner Disease
- Extra-pulmonary manifestations of COVID-19: A comprehensive review
- PNEUMONIA AND DEMODICOSIS IN CROSSBREED POMERANIAN
- Baricitinib: Exploring the Safety Profile for the Treatment of Alopecia Areata
- Acute parenchymal lung involvement in a 68-year-old woman with systemic lupus erythematosus, anemia, and thrombocytopenia
- Potassium channel openers: pharmacological and clinical aspects
- Androgenetic alopecia in COVID-19: Compared to age-matched epidemiologic studies and hospital outcomes with or without the Gabrin sign
- Early COVID-19 Therapy with Azithromycin Plus Nitazoxanide, Ivermectin or Hydroxychloroquine in Outpatient Settings Significantly Reduced Symptoms Compared to Known Outcomes in Untreated Patients.
- Early COVID-19 Therapy with Azithromycin Plus Nitazoxanide, Ivermectin or Hydroxychloroquine in Outpatient Settings Significantly Reduced Symptoms Compared to Known Outcomes in Untreated Patients
- Relation between mineral composition of human hair and common illnesses